Literature DB >> 19336712

Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.

David J Rothman1, Walter J McDonald, Carol D Berkowitz, Susan C Chimonas, Catherine D DeAngelis, Ralph W Hale, Steven E Nissen, June E Osborn, James H Scully, Gerald E Thomson, David Wofsy.   

Abstract

Professional medical associations (PMAs) play an essential role in defining and advancing health care standards. Their conferences, continuing medical education courses, practice guidelines, definitions of ethical norms, and public advocacy positions carry great weight with physicians and the public. Because many PMAs receive extensive funding from pharmaceutical and device companies, it is crucial that their guidelines manage both real and perceived conflict of interests. Any threat to the integrity of PMAs must be thoroughly and effectively resolved. Current PMA policies, however, are not uniform and often lack stringency. To address this situation, the authors first identified and analyzed conflicts of interest that may affect the activities, leadership, and members of PMAs. The authors then went on to formulate guidelines, both short-term and long-term, to prevent the appearance or reality of undue industry influence. The recommendations are rigorous and would require many PMAs to transform their mode of operation and perhaps, to forgo valuable activities. To maintain integrity, sacrifice may be required. Nevertheless, these changes are in the best interest of the PMAs, the profession, their members, and the larger society.

Mesh:

Year:  2009        PMID: 19336712     DOI: 10.1001/jama.2009.407

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  61 in total

1.  Of mugs, meals and more: the intricate relations between physicians and the medical industry.

Authors:  Stephan Sahm
Journal:  Med Health Care Philos       Date:  2013-05

2.  Meta-analyses and conflict of interest.

Authors:  Giovanni A Fava
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

3.  Professional medical organizations and commercial conflicts of interest: ethical issues.

Authors:  Howard Brody
Journal:  Ann Fam Med       Date:  2010 Jul-Aug       Impact factor: 5.166

4.  Partisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.

Authors:  Athina Tatsioni; George C M Siontis; John P A Ioannidis
Journal:  J Gen Intern Med       Date:  2010-04-28       Impact factor: 5.128

5.  Transparency and trust.

Authors:  J E Compston
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

6.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

7.  Orthopaedic surgeons and industry: the value proposition.

Authors:  John J Callaghan; Steve S Liu
Journal:  Iowa Orthop J       Date:  2010

8.  Industry relationships between physicians and professional medical associations: corrupt or essential?

Authors:  C Daniel Smith; Bruce MacFadyen
Journal:  Surg Endosc       Date:  2010-02       Impact factor: 4.584

9.  Does it really matter who's paying for dinner?

Authors:  Mary L Ryan
Journal:  J Med Libr Assoc       Date:  2010-01

Review 10.  Kidney disease: improving global outcomes.

Authors:  Kai-Uwe Eckardt; Bertram L Kasiske
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.